UPDATE: Roth Capital Upgrades Intellia Therapeutics (NTLA) to Buy
Tweet Send to a Friend
(Updated - May 7, 2021 4:59 AM EDT)
Roth Capital analyst Tony Butler upgraded Intellia Therapeutics (NASDAQ: NTLA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Tony Butler upgraded Intellia Therapeutics (NASDAQ: NTLA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
